ACELYRIN, INC. Engages Investors This September at Major Conferences
![ACELYRIN, INC. Engages Investors This September at Major Conferences](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
ACELYRIN, INC. to Participate in Upcoming Investor Conferences
ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company dedicated to accelerating the development and delivery of transformative medicines in immunology, has announced participation in notable investor conferences this September. Members of the management team will hold fireside chats and conduct 1x1 meetings that aim to engage with potential investors and stakeholders.
Key Conferences in September
The company's participation includes several significant events, each providing a platform to discuss its innovative approach and upcoming developments.
Wells Fargo Healthcare Conference 2024
The Wells Fargo Healthcare Conference will occur on a Thursday. ACELYRIN team members will be involved in a fireside chat slated from 1:30 PM to 2:05 PM ET. This event promises to offer valuable insights into ACELYRIN's progress in the biopharmaceutical space.
Morgan Stanley 22nd Annual Global Healthcare Conference
This conference is scheduled for a Friday session where ACELYRIN will participate at 11:30 AM to 12:05 PM ET. The management team will highlight advancements and strategies aimed at bringing their innovative therapies to market.
H.C. Wainwright 26th Annual Global Investment Conference
On another Monday afternoon, ACELYRIN is also set to take part in the H.C. Wainwright Conference. This presentation will provide attendees with insights from 2:00 PM to 2:30 PM ET about the company's ongoing projects and future plans.
Access to Live Webcasts
Live webcasts of these fireside chats will be made accessible on the Company’s website under the Events & Presentations section. Replays of each webcast will also remain available for 30 days post-event, providing further opportunities for investors to catch the latest updates and discussions.
About ACELYRIN, INC.
ACELYRIN, INC. is deeply committed to delivering life-changing treatment options for patients by identifying, acquiring, and accelerating the development and commercialization of transformative medicines. Their lead program, lonigutamab, is a monoclonal antibody delivered subcutaneously. It specifically targets IGF-1R and is currently under investigation for treating thyroid eye disease, asserting ACELYRIN’s dedication to introducing breakthrough therapies into the market.
Contact Information
For more inquiries or detailed information regarding their ongoing projects and business focus, feel free to reach out to:
Tyler Marciniak
Vice President of Investor Relations and Corporate Affairs
investors@acelyrin.com
media@acelyrin.com
Frequently Asked Questions
What is the purpose of the investor conferences ACELYRIN is attending?
The conferences serve as platforms for ACELYRIN’s management to engage with potential investors and stakeholders, discussing new developments and future strategies.
What is ACELYRIN’s lead program?
ACELYRIN’s lead program, lonigutamab, is a monoclonal antibody targeting IGF-1R being investigated for the treatment of thyroid eye disease.
How can investors access the live webcasts?
Investors can access the live webcasts through ACELYRIN’s website under the Events & Presentations section.
What are the dates of the conferences ACELYRIN will attend?
ACELYRIN will participate in conferences on specific dates in September, including the Wells Fargo Healthcare Conference, Morgan Stanley Global Healthcare Conference, and H.C. Wainwright Global Investment Conference.
Who can I contact for more information about ACELYRIN?
For additional inquiries, you can reach out to Tyler Marciniak, the Vice President of Investor Relations and Corporate Affairs at ACELYRIN.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/